Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 64.04B | 62.75B | 61.86B | 60.53B | 57.35B | 55.18B |
Gross Profit | 36.87B | 35.55B | 34.30B | 32.69B | 31.49B | 30.86B |
EBITDA | 12.90B | 12.18B | 14.69B | 7.17B | 12.41B | 10.55B |
Net Income | 5.83B | 6.02B | 7.50B | 1.64B | 5.74B | 5.59B |
Balance Sheet | ||||||
Total Assets | 148.59B | 137.18B | 135.24B | 127.24B | 132.00B | 155.97B |
Cash, Cash Equivalents and Short-Term Investments | 15.45B | 14.59B | 13.44B | 8.74B | 7.25B | 13.81B |
Total Debt | 67.72B | 58.40B | 59.94B | 54.01B | 55.14B | 65.09B |
Total Liabilities | 121.00B | 109.78B | 112.63B | 105.22B | 113.00B | 135.25B |
Stockholders Equity | 27.51B | 27.31B | 22.53B | 21.94B | 18.90B | 20.60B |
Cash Flow | ||||||
Free Cash Flow | 11.81B | 11.76B | 12.12B | 8.46B | 10.03B | 14.97B |
Operating Cash Flow | 13.28B | 13.45B | 13.93B | 10.44B | 12.80B | 18.20B |
Investing Cash Flow | -14.25B | -4.94B | -7.07B | -4.20B | -5.97B | -3.03B |
Financing Cash Flow | -1.85B | -7.08B | -1.77B | -4.96B | -13.35B | -9.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $67.67B | 20.67 | 30.46% | 3.18% | 4.52% | -0.22% | |
74 Outperform | $33.77B | 14.04 | 16.69% | 1.76% | 6.34% | 12.16% | |
71 Outperform | $28.88B | 19.95 | 16.50% | 3.12% | -1.95% | 62.75% | |
70 Outperform | $148.62B | 18.99 | 27.27% | 2.49% | 6.21% | 14.87% | |
68 Neutral | ¥241.23B | 15.39 | 6.62% | 2.45% | 9.02% | -0.57% | |
67 Neutral | $220.12B | 38.33 | 22.73% | 2.84% | 2.69% | -31.73% | |
58 Neutral | $36.50B | 261.59 | 1.01% | 2.12% | 3.64% | 102.21% |
IBM reported strong financial results for the second quarter of 2025, with revenue, profit, and cash flow exceeding expectations. The company’s performance was driven by growth in its Software and Infrastructure segments, particularly with the introduction of the z17 mainframe and advancements in AI and hybrid cloud solutions. IBM’s strategic focus on AI and hybrid cloud continues to yield positive outcomes, as evidenced by significant growth in its GenAI business and recognition as an Emerging Leader in AI consulting. The company also expanded its partner ecosystem and launched new capabilities in its watsonx portfolio, further solidifying its position in the technology industry.
The most recent analyst rating on (IBM) stock is a Buy with a $250.00 price target. To see the full list of analyst forecasts on International Business Machines stock, see the IBM Stock Forecast page.
On June 20, 2025, IBM announced amendments to its existing credit agreements, extending the maturity of its $2.5 billion Three-Year Credit Agreement to June 20, 2028, and its $7.5 billion Five-Year Credit Agreement to June 22, 2030. These amendments, involving major financial institutions like JPMorgan Chase Bank, BNP Paribas, Citibank, and Royal Bank of Canada, are expected to provide IBM with enhanced financial flexibility and stability, potentially impacting its operational strategies and market positioning.
The most recent analyst rating on (IBM) stock is a Buy with a $200.00 price target. To see the full list of analyst forecasts on International Business Machines stock, see the IBM Stock Forecast page.